STOCK TITAN

Illumina (ILMN) Financials

ILMN NASDAQ
Trailing 12 months to September 27, 2026
Revenue $4.5B +5.8% YoY
Net Income $895.0M +27.5% YoY
EPS (Diluted) $5.81 +30.3% YoY
Free Cash Flow $1.1B +5.7% YoY
Market Cap $31.8B as of Nov 18, 2026
Price / Sales 7.0x on $4.5B revenue, trailing 12 months to September 27, 2026
Price / Earnings 35.5x on $895.0M net income, trailing 12 months to September 27, 2026
Price / Book 10.1x on $3.1B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 27, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ILMN SEC filings page.

Illumina Inc (ILMN) reported $4.5B in revenue over the twelve months to Sep 27, 2026, up 5.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ILMN FY2025

With sales nearly flat, FY2025 profitability returned through lower operating costs rather than broader demand.

With revenue contracting 0.7%, the operating margin expanded 37.6 percentage points, so the earnings recovery came from internal cost changes rather than sales growth. The gross-margin improvement was only 0.6 percentage points while research and development fell 17.3%, pointing to cost discipline as the main operating shift.

FY2025 earnings quality is favorable: net income of $850M converted into operating cash flow of $1.1B. That cash conversion reached 126.9% of net income, leaving free cash flow of $931M.

The balance sheet became less burdened by liabilities relative to assets, with that measure at 59.0% while equity increased 14.7%. The company also used $742M for buybacks against $931M of free cash flow, making capital returns a major use of internally generated cash.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 50 / 100
Financial Health Score 50/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Illumina Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
28

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Illumina Inc scores 28/100 on it among other operating companies.

Growth
24

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Illumina Inc scores 24/100 on it among other operating companies.

Leverage
76

Illumina Inc's net debt of $72.0M, being $1.5B of long-term debt less $1.4B of cash, came to 0.07 times its EBITDA in fiscal year 2025. Operating companies are ranked here on long-term debt less cash against their EBITDA, where a lower multiple is the safer one, and Illumina Inc scores 76/100 among other operating companies measured the same way.

Liquidity
61

Illumina Inc held $2.08 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 2.08. Liquidity ranks operating companies on that ratio, and Illumina Inc scores 61/100 among other operating companies.

Cash Flow
81

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Illumina Inc scores 81/100 on it among other operating companies.

Returns
28

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Illumina Inc scores 28/100 on it among other operating companies.

Altman Z-Score Safe
6.14

Illumina Inc scores 6.14, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $31.8B against total liabilities of $3.9B. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong
8/9

Illumina Inc passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality Cash-Backed
1.27x

For every $1 of reported earnings, Illumina Inc generates $1.27 in operating cash flow ($1.1B OCF vs $850.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
7.99x

Illumina Inc earns $7.99 in operating income for every $1 of interest expense ($807.0M vs $101.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.1B
YoY+4.2%
QoQ-2.6%
5Y CAGR+0.4%
10Y CAGR+6.4%

Illumina Inc generated $1.1B in revenue in Q3 2026. This represents an increase of 4.2% from the same quarter a year earlier. Against the prior quarter it is down 2.6%.

EBITDA
$377.0M
YoY+28.2%
QoQ+19.7%
5Y CAGRn/m

Illumina Inc's EBITDA was $377.0M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 28.2% from the same quarter a year earlier. Against the prior quarter it is up 19.7%.

Net Income
$220.0M
YoY+46.7%
QoQ+6.3%
5Y CAGR-7.0%
10Y CAGR+5.5%

Illumina Inc reported $220.0M in net income in Q3 2026. This represents an increase of 46.7% from the same quarter a year earlier. Against the prior quarter it is up 6.3%.

EPS (Diluted)
$1.43
YoY+45.9%
QoQ+5.9%
5Y CAGR-7.2%
10Y CAGR+5.1%

Illumina Inc earned $1.43 per diluted share (EPS) in Q3 2026. This represents an increase of 45.9% from the same quarter a year earlier. Against the prior quarter it is up 5.9%.

Cash & Balance Sheet

Free Cash Flow
$379.0M
YoY+49.8%
QoQ+135.4%
5Y CAGRn/m
10Y CAGR+12.3%

Illumina Inc generated $379.0M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 49.8% from the same quarter a year earlier. Against the prior quarter it is up 135.4%.

Cash & Debt
$1.3B
YoY+22.8%
QoQ+23.9%
5Y CAGR+3.6%
10Y CAGR+5.0%

Illumina Inc held $1.3B in cash against $1.8B in long-term debt as of Q3 2026.

Shares Outstanding
151M
YoY-1.0%
QoQ+0.1%
5Y CAGR-0.7%
10Y CAGR+0.3%

Illumina Inc had 151M shares outstanding in Q3 2026. This represents a decrease of 1.0% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
73.5%
YoY+5.9pp
QoQ+7.1pp
5Y change+4.0pp
10Y change+3.3pp

Illumina Inc's gross margin was 73.5% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 5.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 7.1 percentage points.

Operating Margin
27.0%
YoY+6.1pp
QoQ+5.9pp
5Y change+76.2pp

Illumina Inc's operating margin was 27.0% in Q3 2026, reflecting core business profitability. This is up 6.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.9 percentage points.

Net Margin
19.5%
YoY+5.6pp
QoQ+1.6pp
5Y change-9.1pp
10Y change-1.8pp

Illumina Inc's net profit margin was 19.5% in Q3 2026, showing the share of revenue converted to profit. This is up 5.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.6 percentage points.

Return on Equity
7.0%
YoY+0.7pp
QoQ-0.3pp
5Y change+4.0pp
10Y change+1.2pp

Illumina Inc's quarterly ROE was 7.0% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.3 percentage points.

Capital Allocation

R&D Spending
$244.0M
YoY+6.6%
QoQ-3.2%
5Y CAGR-11.0%

Illumina Inc invested $244.0M in research and development in Q3 2026. This represents an increase of 6.6% from the same quarter a year earlier. Against the prior quarter it is down 3.2%.

Share Buybacks
$9.0M
YoY-93.1%
QoQ-93.0%

Illumina Inc spent $9.0M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 93.1% from the same quarter a year earlier. Against the prior quarter it is down 93.0%.

Capital Expenditures
$40.0M
YoY+29.0%
QoQ0.0%
5Y CAGR-5.1%
10Y CAGR-3.5%

Illumina Inc invested $40.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 29.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

ILMN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ILMN quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$1.1B+4.2%$1.2B+9.4%$1.1B+4.8%$1.2B+5.0%$1.1B+0.4%$1.1B-4.8%$1.0B-3.3%$1.1B-1.6%
Cost of Revenue$299.0M-14.8%$389.0M+6.9%$370.0M+3.4%$400.0M+6.4%$351.0M+4.8%$364.0M-6.9%$358.0M-12.5%$376.0M-16.3%
Gross Profit$830.0M+13.2%$770.0M+10.8%$721.0M+5.6%$759.0M+4.3%$733.0M-1.6%$695.0M-3.6%$683.0M+2.4%$728.0M+8.2%
R&D Expenses$244.0M+6.6%$252.0M+2.0%$240.0M-4.8%$239.0M-5.2%$229.0M-9.5%$247.0M-24.0%$252.0M-25.7%$252.0M-25.9%
SG&A Expenses$281.0M+1.4%$273.0M+16.7%$272.0M+1.9%$308.0M+15.4%$277.0M+15.9%$234.0M+59.2%$267.0M-39.2%$267.0M-43.1%
Operating Income$305.0M+34.4%$245.0M+14.5%$209.0M+27.4%$202.0M+16.1%$227.0M-69.4%$214.0Mn/m$164.0Mn/m$174.0Mn/m
EBITDA$377.0M+28.2%$315.0M+11.7%$278.0M+19.3%$268.0M+9.4%$294.0M-63.7%$282.0Mn/m$233.0Mn/m$245.0Mn/m
Interest Expense$24.0M-4.0%$24.0M-4.0%$24.0M-4.0%$26.0M0.0%$25.0M-30.6%$25.0M+25.0%$25.0M+38.9%$26.0M+36.8%
Income Tax$44.0M-37.1%$53.0M-25.4%$23.0M-54.9%$44.0Mn/m$70.0M+366.7%$71.0M+491.7%$51.0M+200.0%$0-100.0%
Net Income$220.0M+46.7%$207.0M-11.9%$134.0M+2.3%$334.0M+79.6%$150.0M-78.7%$235.0Mn/m$131.0Mn/m$186.0Mn/m
EPS (Basic)$1.46+49.0%$1.37-8.1%$0.88+6.0%$2.17+85.5%$0.98-77.9%$1.49n/m$0.83n/m$1.17n/m
EPS (Diluted)$1.43+45.9%$1.35-9.4%$0.87+6.1%$2.16+84.6%$0.98-77.8%$1.49n/m$0.82n/m$1.17n/m
Diluted Shares (Avg)154M0.0%153M-2.5%154M-3.1%N/A154M-3.8%157M-1.3%159M0.0%N/A

ILMN Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ILMN quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$6.8B+10.3%$6.7B+9.2%$6.6B+6.1%$6.6B+5.4%$6.2B+2.7%$6.1B+0.1%$6.2B-38.4%$6.3B-37.7%
Current Assets$3.0B+8.5%$2.8B+7.3%$2.7B+2.4%$3.3B+19.8%$2.8B+17.8%$2.6B+7.4%$2.7B+3.5%$2.7B+5.3%
Cash & Equivalents$1.3B+22.8%$1.0B+11.3%$1.1B-2.2%$1.4B+25.8%$1.1B+20.8%$934.0M+1.5%$1.1B+0.5%$1.1B+7.5%
Short-Term Investments$48.0M-78.9%$128.0M-42.1%$66.0M-46.8%$215.0M+131.2%$228.0M+225.7%$221.0M+198.6%$124.0Mn/m$93.0M+1450.0%
Inventory$667.0M+13.1%$629.0M+9.4%$611.0M+13.8%$564.0M+3.1%$590.0M+2.8%$575.0M+2.5%$537.0M-8.0%$547.0M-6.8%
Accounts Receivable$738.0M+1.2%$764.0M+9.0%$738.0M+5.6%$854.0M+16.2%$729.0M+4.3%$701.0M+9.4%$699.0M+10.1%$735.0M+0.1%
Long-Term InvestmentsN/AN/AN/AN/A$0n/m$0$0n/mN/A
Goodwill$1.3B+15.4%$1.3B+15.4%$1.3B+15.4%$1.1B0.0%$1.1B0.0%$1.1B+3.2%$1.1B-56.3%$1.1B-56.3%
Total Liabilities$3.7B-3.4%$3.8B-0.4%$3.9B+1.8%$3.9B-0.2%$3.8B-2.4%$3.8B-17.6%$3.8B-11.4%$3.9B-10.0%
Current Liabilities$1.2B-41.1%$1.6B+8.0%$1.6B+8.8%$1.6B+2.5%$2.0B+101.2%$1.5B-33.8%$1.4B-2.3%$1.5B-1.5%
Non-Current Liabilities$2.5B+36.9%$2.2B-5.7%$2.3B-2.4%$2.3B-2.0%$1.8B-37.1%$2.4B-2.8%$2.4B-16.2%$2.4B-14.8%
Long-Term Debt$1.8B+80.0%$1.5B-0.1%$1.5B-0.1%$1.5B0.0%$994.0M-50.0%$1.5B+0.1%$1.5B+0.1%$1.5B+0.1%
Total Equity$3.1B+32.1%$2.8B+25.7%$2.7B+13.0%$2.7B+14.7%$2.4B+12.0%$2.3B+57.2%$2.4B-58.7%$2.4B-58.7%
Retained Earnings$169.0Mn/m-$51.0Mn/m-$258.0Mn/m-$392.0Mn/m-$726.0Mn/m-$876.0Mn/m-$1.1Bn/m-$1.2Bn/m

ILMN Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ILMN quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$419.0M+47.5%$201.0M-14.1%$289.0M+20.4%$321.0M-11.8%$284.0M-10.1%$234.0M+192.5%$240.0M+211.7%$364.0M+62.5%
Depreciation & Amortization$72.0M+7.5%$70.0M+2.9%$69.0M0.0%$66.0M-7.0%$67.0M-4.3%$68.0M-35.2%$69.0M-36.1%$71.0M-34.9%
Stock-Based Compensation$75.0M+7.1%$72.0M+4.3%$60.0M-17.8%N/A$70.0M-16.7%$69.0M-37.3%$73.0M-24.0%N/A
Capital Expenditures$40.0M+29.0%$40.0M+33.3%$38.0M+18.8%$55.0M+89.7%$31.0M-3.1%$30.0M-3.2%$32.0M-11.1%$29.0M-43.1%
Free Cash Flow$379.0M+49.8%$161.0M-21.1%$251.0M+20.7%$266.0M-20.6%$253.0M-10.9%$204.0M+316.3%$208.0M+407.3%$335.0M+93.6%
Investing Cash Flow$50.0Mn/m-$122.0Mn/m-$366.0Mn/m$108.0Mn/m-$51.0Mn/m-$49.0Mn/m-$63.0Mn/m-$48.0Mn/m
Financing Cash Flow-$222.0Mn/m-$129.0Mn/m-$251.0Mn/m-$63.0Mn/m-$115.0Mn/m-$371.0Mn/m-$195.0M-657.1%-$47.0Mn/m
Share Buybacks$9.0M-93.1%$128.0M-65.4%$242.0M+21.0%$42.0M+147.1%$130.0M+31.3%$370.0Mn/m$200.0Mn/m$17.0Mn/m

Not reported in any period shown, so not listed: Dividends Paid.

ILMN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ILMN quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin73.5%+5.9pp66.4%+0.8pp66.1%+0.5pp65.5%-0.4pp67.6%-1.4pp65.6%+0.8pp65.6%+3.6pp65.9%+6.0pp
Operating Margin27.0%+6.1pp21.1%+0.9pp19.2%+3.4pp17.4%+1.7pp20.9%-47.7pp20.2%15.8%+26.1pp15.8%+30.3pp
Net Margin19.5%+5.6pp17.9%-4.3pp12.3%-0.3pp28.8%+12.0pp13.8%-51.4pp22.2%12.6%+24.3pp16.9%+32.5pp
Return on Equity7.0%+0.7pp7.3%-3.1pp5.0%-0.5pp12.3%+4.4pp6.3%-26.9pp10.4%+148.9pp5.5%+7.7pp7.8%+10.9pp
Return on Assets3.2%+0.8pp3.1%-0.8pp2.0%-0.1pp5.0%+2.1pp2.4%-9.3pp3.9%+36.6pp2.1%+3.4pp2.9%+4.7pp
Current Ratio2.63+1.2x1.800.0x1.75-0.1x2.08+0.3x1.43-1.0x1.81+0.7x1.86+0.1x1.78+0.1x
Debt-to-Equity0.57+0.2x0.53-0.1x0.56-0.1x0.55-0.1x0.42-0.5x0.66-0.4x0.63+0.4x0.63+0.4x
Liabilities-to-Equity1.17-0.4x1.34-0.4x1.45-0.2x1.44-0.2x1.59-0.2x1.70-1.5x1.61+0.9x1.66+0.9x
Asset Turnover0.170.0x0.170.0x0.170.0x0.170.0x0.180.0x0.170.0x0.17+0.1x0.18+0.1x
FCF Margin33.6%+10.2pp13.9%-5.4pp23.0%+3.0pp22.9%-7.4pp23.3%-3.0pp19.3%+14.8pp20.0%+16.2pp30.3%+14.9pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Illumina Inc ILMN FY2025 $4.3B $850.0M 19.6% $31.8B 50/100
Labcorp Holdings Inc. LH FY2025 $14.0B $876.5M 6.3% $30.1B 52/100
Quest Diagnostics Inc. DGX FY2025 $11.0B $992.0M 9.0% $28.6B 56/100
Mettler-Toledo International MTD FY2025 $4.0B $869.2M 21.6% $34.6B 59/100
IQVIA Holdings Inc. IQV FY2025 $16.3B $1.4B 8.3% $42.5B 50/100
Natera, Inc. NTRA FY2025 $2.3B -$208.2M -9.0% $42.0B 52/100

Frequently Asked Questions

Illumina Inc (ILMN) reported $4.3B in total revenue for fiscal year 2025. This represents a -0.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Illumina Inc (ILMN) revenue declined by 0.7% year-over-year, from $4.4B to $4.3B in fiscal year 2025.

Yes, Illumina Inc (ILMN) reported a net income of $895.0M over the trailing 12 months to September 27, 2026. In fiscal year 2025 it reported a net income of $850.0M, with a net profit margin of 19.6%.

Illumina Inc (ILMN) reported diluted earnings per share of $5.45 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Illumina Inc (ILMN) had EBITDA of $1.1B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Illumina Inc (ILMN) had $1.4B in cash and equivalents against $1.5B in long-term debt.

Illumina Inc (ILMN) had a gross margin of 66.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Illumina Inc (ILMN) had an operating margin of 18.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Illumina Inc (ILMN) had a net profit margin of 19.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Illumina Inc (ILMN) has a return on equity of 31.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Illumina Inc (ILMN) generated $931.0M in free cash flow during fiscal year 2025. This represents a 31.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Illumina Inc (ILMN) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Illumina Inc (ILMN) had $6.6B in total assets as of fiscal year 2025, including both current and long-term assets.

Illumina Inc (ILMN) invested $148.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Illumina Inc (ILMN) invested $967.0M in research and development during fiscal year 2025.

Yes, Illumina Inc (ILMN) spent $742.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Illumina Inc (ILMN) had 153M shares outstanding as of fiscal year 2025.

Illumina Inc (ILMN) had a current ratio of 2.08 as of fiscal year 2025, which is generally considered healthy.

Illumina Inc (ILMN) had a debt-to-equity ratio of 0.55 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Illumina Inc (ILMN) had a liabilities-to-equity ratio of 1.44 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Illumina Inc (ILMN) had a return on assets of 12.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Illumina Inc (ILMN) trades at 35.5x earnings, its market capitalization divided by $895.0M net income, trailing 12 months to September 27, 2026. The market capitalization is $31.8B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Illumina Inc (ILMN) trades at 7.0x sales, its market capitalization divided by $4.5B revenue, trailing 12 months to September 27, 2026. The market capitalization is $31.8B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Illumina Inc (ILMN) has an Altman Z-Score of 6.14, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Illumina Inc (ILMN) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Illumina Inc (ILMN) has an earnings quality ratio of 1.27x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Illumina Inc (ILMN) has an interest coverage ratio of 7.99x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Illumina Inc (ILMN) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top